KalVista Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsKalVista Pharmaceuticals

KalVista Pharmaceuticals(KALV)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Annual sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

No data

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

hereditary angioedema types i and ii

,

hereditary angioedemas

,

Hyaluronate sodium

non-small-cell lung carcinoma

,

stomach neoplasms

,

healthy volunteers/patients

,

pancreatic neoplasms

,

breast neoplasms

,

pancreatic ductal carcinoma

,

,

ductal carcinoma

,

postoperative nausea and vomiting

,

,

viral hepatitis human

,

,

neurologic manifestations

,

brain neoplasms

,

,

,

biliary tract neoplasms

,

,

follicular lymphoma

,

,

microsatellite instability

,

squamous cell neoplasms

,

large cell carcinoma

,

chronic obstructive pulmonary disease

,

,

cholangiocarcinoma

,

,

mouth neoplasms

,

oropharyngeal neoplasms

,

laryngeal neoplasms

,

hypopharyngeal neoplasms

,

b-cell lymphoma marginal zone

,

mantle-cell lymphoma

,

endometrial neoplasms

,

transitional cell carcinoma

,

uterine cervical neoplasms

,

cutaneous malignant melanoma

,

type 2 diabetes mellitus

,

diabetes mellitus

,

non-small-cell lung carcinoma

,

,

,

,

breast neoplasms

,

,

communicable diseases

,

,

chronic hepatitis c

,

,

,

triple negative breast neoplasms

,

neoplasm metastasis

,

,

colorectal neoplasms

,

stomach neoplasms

,

esophageal neoplasms

,

,

squamous cell carcinoma of head and neck

,

head and neck neoplasms

,

ovarian neoplasms

,

,

chronic hepatitis

,

,

,

squamous cell carcinoma

,

sleep initiation and maintenance disorders

,

,

clostridium infections

,

multiple myeloma

,

plasma cell neoplasms

,

hodgkin disease

,

,

ovarian epithelial carcinoma

,

migraine disorders

,

castration-resistant prostatic neoplasms

,

pancreatic neoplasms

,

,

essential hypertension

,

nasopharyngeal neoplasms

,

acquired immunodeficiency syndrome

,

,

chronic renal insufficiency

,

kidney diseases

,

hepatocellular carcinoma

,

general anesthesia

,

neuromuscular blockade

,

intraabdominal infections

,

urinary tract infections

,

malignant mesothelioma

,

,

postmenopausal osteoporosis

,

hypercholesterolemia

,

alzheimer disease

,

,

erectile dysfunction

,

renal cell carcinoma

,

surgical wound infection

,

bacterial skin diseases

,

bacterial infections

,

staphylococcal infections

,

,

immunologic deficiency syndromes

,

urinary bladder neoplasms

,

,

type 1 diabetes mellitus

,

cytomegalovirus infections

,

,

glucose metabolism disorders

,

metabolic diseases

,

endocrine system diseases

,

allergic rhinitis

,

,

allergic rhinitis seasonal

,

liver neoplasms

,

fallopian tube neoplasms

,

,

,

bacterial pneumonia

,

,

,

,

,

hepatic insufficiency

,

,

prostatic hyperplasia

,

,

,

cognitive dysfunction

,

,

,

prostatic neoplasms

,

plexiform neurofibroma

,

neurofibromatosis 1

,

hereditary breast and ovarian cancer syndrome

,

,

central nervous system neoplasms

,

nervous system neoplasms

,

rheumatoid arthritis

,

,

hip osteoarthritis

,

surgical blood loss

,

replacement arthroplasty hip

,

knee osteoarthritis

,

knee osteoarthritis

,

,

physiological stress

,

hypersensitivity

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use